A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1999
12/02/1999	CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999	CA2329156A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999	CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999	CA2329053A1 Human socs proteins
12/02/1999	CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999	CA2328604A1 Compositions and methods of modulating an immune response to an antigen
12/02/1999	CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999	CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999	CA2327541A1 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999	CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/01/1999	EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/01/1999	EP0960335A2 Modulators of insulin receptor activity
12/01/1999	EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999	EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999	EP0960192A1 Synthetic polynucleotides
12/01/1999	EP0960141A1 Cross-linked vinyl polymers with bile acid adsorbing effect
12/01/1999	EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
12/01/1999	EP0960118A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
12/01/1999	EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999	EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
12/01/1999	EP0960110A1 3-ARYL SUBSTITUTED PYRAZOLO 4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF 1?) SPECIFIC LIGANDS
12/01/1999	EP0960108A1 Matrix metalloproteinase inhibitors
12/01/1999	EP0960106A1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
12/01/1999	EP0960103A1 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)
12/01/1999	EP0960102A1 AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN
12/01/1999	EP0960101A1 4-aminoethoxyindazole derivatives
12/01/1999	EP0960096A1 SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS
12/01/1999	EP0959899A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
12/01/1999	EP0959897A1 Method of regulating nitric oxide production
12/01/1999	EP0959886A1 Triaryl substituted imidazoles as glucagon antagonists
12/01/1999	EP0959885A1 Triaryl substituted imidazoles and methods of use
12/01/1999	EP0959884A1 Phosphatase inhibitors and methods of use thereof
12/01/1999	EP0959882A1 N-linked ureas and carbamates of heterocyclic thioesters
12/01/1999	EP0959878A1 Method for treating renal failure
12/01/1999	EP0959877A1 Correction of genetic defects using chemical chaperones
12/01/1999	EP0959781A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
12/01/1999	EP0850235B1 Quinolein-2(1h)-one derivatives as serotonin antagonists
12/01/1999	EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999	EP0788491B1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
12/01/1999	EP0655056B1 Azacyclyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
12/01/1999	EP0630244B1 Muscarinic agonists
12/01/1999	CN1237177A Fused bicyclic pyrimidine derivatives
12/01/1999	CN1237169A Tricyclic compounds useful for inhibition of G-protein function and treatment of proliferative diseases
12/01/1999	CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999	CN1237160A Process for preparing substituted pyridines
12/01/1999	CN1237159A Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing same and their use in medicaments
12/01/1999	CN1236780A Pyrazolopyrimidines and pyrazolotriazines
12/01/1999	CN1236775A Process for preparation of 4-(des-dimethylamino)-tetracyclines
12/01/1999	CN1046942C Imidazopyridines
12/01/1999	CN1046939C Fluoroalkoxy-substituted benzamides and their preparing process and use
11/1999
11/30/1999	US5994616 Targeted synthesis of protein in mammary gland of a non-human transgenic mammal
11/30/1999	US5994537 Process for preparing azepinone compounds useful in the inhibition of ACE and NEP
11/30/1999	US5994535 Water soluble texaphyrin metal complex preparation
11/30/1999	US5994513 Oncoprotein protein kinase
11/30/1999	US5994511 Anti-IgE antibodies and methods of improving polypeptides
11/30/1999	US5994500 Antagonists of intestinotrophic GLP-2 peptides
11/30/1999	US5994397 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
11/30/1999	US5994396 Nervous system disorders; autoimmune diseases; antiinflammatory agents
11/30/1999	US5994391 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
11/30/1999	US5994384 Hypersensitization of adrenergic receptors
11/30/1999	US5994381 Antipyretics; antiinflammatory agents; analgesics
11/30/1999	US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999	US5994378 Antiallergens; antiinflammatory agents
11/30/1999	US5994372 Peripherally active anti-hyperalgesic opiates
11/30/1999	US5994371 Carbamate derivatives of 3-aroylbenzo[b] thiophenes
11/30/1999	US5994368 Antiallergens, antiinflammatory agents, analgesics
11/30/1999	US5994367 Method for treating tumors using 2-aryl-naphthyridin-4-ones
11/30/1999	US5994353 Aromatic compounds and pharmaceutical compositions containing them
11/30/1999	US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999	US5994344 Bronchitis therapy
11/30/1999	US5994340 Synergistic mixture with antibiotics
11/30/1999	US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999	US5994313 Regulated apoptosis
11/30/1999	US5994312 Peptidyl compounds
11/30/1999	US5994311 Using a oligopeptides, polypeptide
11/30/1999	US5994303 Use of insulin and IGF-I
11/30/1999	US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999	US5994300 Vascular endothelial cell growth factor C subunit
11/30/1999	US5994299 Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them
11/30/1999	US5994298 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof
11/30/1999	US5994295 Therapeutic system for dietary health management
11/30/1999	US5994293 Peptidyl compounds and their therapeutic use
11/30/1999	US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/30/1999	US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999	US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999	US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999	US5994106 Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
11/30/1999	US5994101 DNA encoding gidA1 polypeptides
11/30/1999	US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999	US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999	US5994096 Regulator
11/30/1999	US5994094 A bone morphogenetic protein; treatment of osteoporosis, prevent transplant rejection; wound healing agents; regeneration of bones, cartilage, connective tissue, skin, mucous membranes, epithelium and teeth
11/30/1999	US5993867 Capsules containing freeze-dried, powdered green tea leaves
11/30/1999	US5993845 Histone deacetylase inhibitor and a pharmaceutically acceptable carrier wherein the composition comprises from 0.05 to 100 mg of the histone deacetylase inhibitor.
11/30/1999	US5993833 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition
11/30/1999	US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999	US5993811 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
11/30/1999	US5993774 Metal-oxime chelates for use as radiopharmaceutical agents
11/30/1999	CA2179011C 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
11/30/1999	CA2030795C Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient

1 ... 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 ... 1564